litlas
ログインアカウント作成

Christine Chevreau

1992–2024 年に発表

135
論文数
27,323
被引用数
81
h 指数
134
i10 指数

被引用数

Christine Chevreau の年別被引用数1956 年: 被引用 1 件1991 年: 被引用 1 件1993 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 5 件1997 年: 被引用 16 件1998 年: 被引用 13 件1999 年: 被引用 21 件2000 年: 被引用 31 件2001 年: 被引用 22 件2002 年: 被引用 36 件2003 年: 被引用 31 件2004 年: 被引用 37 件2005 年: 被引用 47 件2006 年: 被引用 55 件2007 年: 被引用 121 件2008 年: 被引用 183 件2009 年: 被引用 221 件2010 年: 被引用 224 件2011 年: 被引用 206 件2012 年: 被引用 193 件2013 年: 被引用 192 件2014 年: 被引用 131 件2015 年: 被引用 119 件2016 年: 被引用 138 件2017 年: 被引用 161 件2018 年: 被引用 128 件2019 年: 被引用 542 件2020 年: 被引用 691 件2021 年: 被引用 718 件2022 年: 被引用 658 件2023 年: 被引用 525 件2024 年: 被引用 912 件2025 年: 被引用 371 件2026 年: 被引用 5 件1957〜1990 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,274 件、この内訳の 23.5%フランス: 引用元論文 783 件、この内訳の 8.1%中国: 引用元論文 729 件、この内訳の 7.5%イタリア: 引用元論文 684 件、この内訳の 7.1%イギリス: 引用元論文 597 件、この内訳の 6.2%ドイツ: 引用元論文 542 件、この内訳の 5.6%オランダ: 引用元論文 387 件、この内訳の 4%カナダ: 引用元論文 372 件、この内訳の 3.9%スペイン: 引用元論文 339 件、この内訳の 3.5%日本: 引用元論文 290 件、この内訳の 3%スイス: 引用元論文 230 件、この内訳の 2.4%ベルギー: 引用元論文 204 件、この内訳の 2.1%
0%23.5%その他 23.1%

機関

分野

  • Medicine81.1%
  • Biochemistry, Genetics and Molecular Biology12%
  • Immunology and Microbiology4.2%
  • Neuroscience0.4%
  • Engineering0.4%
  • Materials Science0.4%
  • その他1.5%

トピック

  • Renal cell carcinoma treatment8.5%
  • Sarcoma Diagnosis and Treatment6.4%
  • Cancer Immunotherapy and Biomarkers5.4%
  • Bladder and Urothelial Cancer Treatments4%
  • Cancer Genomics and Diagnostics2.6%
  • Renal and related cancers2.6%
  • その他70.5%

共著者

全論文

検索で開く
  1. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

    著者: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Yen‐Hwa Chang, Jaroslav Hájek, Stefan N. Symeonides, Jae‐Lyun Lee, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross‐Goupil, Mauricio Mahave, Naomi B. Haas, Piotr Sawrycki, Howard Gurney, Christine Chevreau, Bohuslav Melichar, Evgeniy Kopyltsov, Ajjai Alva, John M. Burke, Gurjyot K. Doshi, Delphine Topart, Stéphane Oudard, Hans J. Hammers, Hiroshi Kitamura, Jens Bedke, Rodolfo F. Perini, Pingye Zhang, Kentaro Imai, Jaqueline Willemann-Rogerio, David I. Quinn, Thomas Powles - New England Journal of Medicine 2021 被引用: 746

  2. Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort

    著者: Antoîne Italiano, Alban Bessede, M. Pulido, Emmanuelle Bompas, Sophie Piperno‐Neumann, Christine Chevreau, Nicolas Penel, François Bertucci, Maud Toulmonde, Carine Bellera, Jean‐Philippe Guégan, Christophe Rey, Catherine Sautès‐Fridman, Antoine Bougoüin, Coralie Cantarel, Michèle Kind, M. Spalato, Bérengère Dadone‐Montaudié, François Le Loarer, Jean‐Yves Blay, Wolf H. Fridman - Nature Medicine 2022 被引用: 263

  3. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    著者: Thomas Powles, Michiel S. van der Heijden, Daniel Castellano, Matthew D. Galsky, Yohann Loriot, Daniel P. Petrylak, Osamu Ogawa, Se Hoon Park, Jae‐Lyun Lee, Ugo De Giorgi, Martin Bögemann, Aristotelis Bamias, Bernhard J. Eigl, Howard Gurney, Som D. Mukherjee, Yves Fradet, Iwona Skoneczna, Marinos Tsiatas, Andrey Novikov, Cristina Suárez, André P. Fay, Ignacio Durán, Andrea Necchi, Sophie Wildsmith, Philip He, Natasha Angra, Ashok Gupta, Wendy J. Levin, Joaquim Bellmunt, Se Hoon Park, Michiel S. van der Heijden, Andrea Necchi, Daniel Castellano, Aristotelis Bamias, Jae‐Lyun Lee, Ugo De Giorgi, Martin Bögemann, Bernhard J. Eigl, Marinos Tsiatas, Thomas Powles, Andrey Novikov, Iwona Skoneczna, Som D. Mukherjee, Cristina Suárez, Hans M. Westgeest, Yves Fradet, Aude Fléchon, Yen‐Chuan Ou, Inkeun Park, Vsevolod Matveev, Begoña Pérez‐Valderrama, Susanna Cheng, Stephen Jay Frank, Howard Gurney, Urbano Anido, Alketa Hamzaj, Margitta Retz, Srikala S. Sridhar, Giorgio V. Scagliotti, Jens Voortman, B. Yа. Alekseev, Anna Alyasova, B. K. Komyakov, Herlinde Dumez, Michel Pavic, Go Kimura, Atsushi Mizokami, Susanne Osanto, José Ángel Arranz, Djura Piersma, Sang Joon Shin, O. B. Karyakin, Ignacio Delgado, José Luis González, See‐Tong Pang, Anna Tran, Oleg Lipatov, Wen-Pin Su, Thomas W. Flaig, Ajjai Alva, Hwa Park Kyong, Evgeny Kopyltsov, Elena Almagro, M. Doménech, Yen‐Hwa Chang, Brieuc Sautois, Andre Ravaux, Gerasimos Aravantinos, V. Georgoulias, Sasja F. Mulder, Yu Jung Kim, Fabio Kater, Christine Chevreau, Scott T. Tagawa, Paweł Zalewski, Florence Joly, Yohann Loriot, Gencay Hatiboglu, Luca Gianni, Franco Morelli ほか 127 名 - The Lancet Oncology 2020 被引用: 498

  4. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Thomas Powles, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Stefan N. Symeonides, Jaroslav Hájek, Howard Gurney, Yen‐Hwa Chang, Jae‐Lyun Lee, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross‐Goupil, Mauricio Mahave, Naomi B. Haas, Piotr Sawrycki, Joseph E. Burgents, Lei Xu, Kentaro Imai, David I. Quinn, Toni K. Choueiri, Piotr Tomczak, Toni K. Choueiri, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Jaroslav Hájek, Tzu-Ping Lin, Stefan N. Symeonides, Jae‐Lyun Lee, Piotr Sawrycki, Naomi B. Haas, Howard Gurney, Mauricio Mahave, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross‐Goupil, Christine Chevreau, John M. Burke, Gurjyot K. Doshi, Bohuslav Melichar, Delphine Topart, Stéphane Oudard, Evgeniy Kopyltsov, H. Hammers, David I. Quinn, Ajjai Alva, Juliana de Menezes, Adriano Gonçalves e Silva, Eric Winquist, Alketa Hamzaj, Giuseppe Procopio, Boguslawa Karaszewska, Ewa M. Nowakowska-Zajdel, B. Yа. Alekseev, Rustem Gafanov, А. А. Измайлов, Andrey Semenov, S. G. Afanasyev, Oleg Lipatov, T.B. Powles, Sandy Srinivas, David F. McDermott, Samith T. Kochuparambil, Ian D. Davis, Katriina Peltola, Roberto Sabbatini, Jinsoo Chung, М. I. Shkolnik, В. Б. Матвеев, P. Gajate Borau, Steven McCune, Thomas E. Hutson, Alejandro Dri, Silvio Correia Sales, Carrie Yeung, Carmen Marcela Alcala Castro, Peter J. Boström, Brigitte Laguerre, Consuelo Buttigliero, Ugo De Giorgi, Eugeniy A. Fomin, Yousef Zakharia, Clara Hwang, Eric A. Singer, Jeffrey T. Yorio, David Waterhouse, Rubén Dario Kowalyszyn, Margarita Sonia Alfie, Eduardo Yañez Ruiz, Tomáš Büchler, Krista Kankaanranta, G. Ferretti, Go Kimura, Kazuo Nishimura, Naoya Masumori, Satoshi Tamada, Haruaki Kato, Hiroshi Kitamura, Iwona Danielewicz ほか 133 名 - The Lancet Oncology 2022 被引用: 278

  5. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

    著者: Arnaud Méjean, Alain Ravaud, Simon Thézenas, Sandra Colas, Jean‐Baptiste Beauval, Karim Bensalah, Lionnel Geoffrois, Antoine Thiery-Vuillemin, Luc Cormier, Hervé Lang, Laurent Guy, Gwénaëlle Gravis, Frédéric Rolland, Claude Linassier, É. Lechevallier, Christian Beisland, Michael Aitchison, Stéphane Oudard, Jean‐Jacques Patard, C Théodore, Christine Chevreau, Brigitte Laguerre, Jacques Hubert, Marine Gross‐Goupil, Jean‐Christophe Bernhard, Laurence Albigès, Marc‐Olivier Timsit, Thierry Lebrét, Bernard Escudier - New England Journal of Medicine 2018 被引用: 940

  6. Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

    著者: Maud Toulmonde, Nicolas Penel, Julien Adam, Christine Chevreau, Jean‐Yves Blay, Axel Le Cesne, Emmanuelle Bompas, Sophie Piperno‐Neumann, Sophie Cousin, Thomas Grellety, Thomas Ryckewaert, Alban Bessede, François Ghiringhelli, Marina Pulido, Antoîne Italiano - JAMA Oncology 2017 被引用: 394

  7. Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

    著者: Robert J. Motzer, Bernard Escudier, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Elizabeth R. Plimack, Giuseppe Procopio, David F. McDermott, Daniel Castellano, Toni K. Choueiri, Frede Donskov, Howard Gurney, Stéphane Oudard, Martin Eduardo Richardet, Katriina Peltola, Ajjai Alva, Michael A. Carducci, John Wagstaff, Christine Chevreau, Satoshi Fukasawa, Yoshihiko Tomita, Thomas Gauler, Christian Kollmannsberger, Fabio A.B. Schutz, James Larkin, David Cella, M. Brent McHenry, Shruti Shally Saggi, Nizar M. Tannir - Cancer 2020 被引用: 337

  8. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

    著者: Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, Michael Siebels, Sylvie Négrier, Christine Chevreau, E Solska, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sara M. Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M. Bukowski - New England Journal of Medicine 2007 被引用: 4,784

  9. Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial

    著者: Antoîne Italiano, Olivier Mir, Simone Mathoulin‐Pélissier, Nicolas Penel, Sophie Piperno‐Neumann, Emmanuelle Bompas, Christine Chevreau, Florence Duffaud, Natacha Entz‐Werlé, Esma Saâda, I. L. Ray-Coquard, Cyril Lervat, Nathalie Gaspar, Perrine Marec‐Bérard, Hélène Pacquement, John Wright, Maud Toulmonde, Alban Bessede, Amandine Crombé, Michèle Kind, Carine Bellera, Jean-Yves Blay - The Lancet Oncology 2020 被引用: 322

  10. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial

    著者: Patricia Pautier, Antoîne Italiano, Sophie Piperno‐Neumann, Christine Chevreau, Nicolas Penel, Nelly Firmin, Pascaline Boudou‐Rouquette, François Bertucci, Corinne Balleyguier, Valérie Lebrun-Ly, Isabelle Ray‐Coquard, Elsa Kalbacher, A. Bardet, Emmanuelle Bompas, Olivier Collard, Nicolás Isambert, Cécile Guillemet, María Rios, Baptiste Archambaud, Florence Duffaud, Antoîne Italiano, Patricia Pautier, A. Lecesne, Sophie Piperno‐Neumann, Christine Chevreau, Didier Cupissol, Nicolas Penel, Jérôme Alexandre, François Bertucci, Isabelle Ray‐Coquard, Valérie Lebrun-Ly, Elsa Kalbacher, Florence Duffaud, Corinne Delcambre, Emmanuelle Bompas, Olivier Collard, Nicolás Isambert, Cécile Guillemet, P Soulié, María Rios, Esma Saâda-Bouzid - The Lancet Oncology 2022 被引用: 125

  11. Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial

    著者: Christian Pfister, Gwenaelle Gravis, Aude Fléchon, Christine Chevreau, Hakim Mahammedi, Brigitte Laguerre, Aline Guillot, Florence Joly, Michel Soulié, Yves Allory, Valentin Harter, Stéphane Culine, for the VESPER Trial Investigators - Journal of Clinical Oncology 2022 被引用: 193

  12. Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma

    著者: Guillaume Davidson, Alexandra Helleux, Yann Vano, Véronique Lindner, Antonin Fattori, Marie Cerciat, Réza Elaidi, Virginie Verkarre, Cheng‐Ming Sun, Christine Chevreau, Mostefa Bennamoun, Hervé Lang, Thibault Tricard, Wolf H. Fridman, Catherine Sautès‐Fridman, Xiaoping Su, Damien Plassard, Céline Keime, Christelle Thibault-Carpentier, Philippe Barthélémy, Stéphane Oudard, Irwin Davidson, Gabriel G. Malouf - Cancer Research 2023 被引用: 88

  13. Surgery in reference centers improves survival of sarcoma patients: a nationwide study

    著者: Jean‐Yves Blay, Charles Honoré, Eberhard Stoeckle, Pierre Méeus, Mehrdad Jafari, F. Gouin, Philippe Anract, Gwénaël Ferron, Alexandre Rochwerger, M. Ropars, Sébastien Carrère, Frédéric Marchal, François Sirveaux, A. Di Marco, Louis‐Romée Le Nail, Jérôme Guiramand, Gualter Vaz, Jean-Christophe Machiavello, O. Marco, Sylvain Causeret, Pierre Gimbergues, F. Fiorenza, L. Chaigneau, F. Guillemin, Jean‐Marc Guilloit, F. Dujardin, Jean‐Philippe Spano, J Ruźić, Audrey Michot, Pauline Soibinet, Emmanuelle Bompas, Christine Chevreau, Florence Duffaud, María Rios, Christophe Perrin, Nelly Firmin, François Bertucci, C. Le Péchoux, François Le Loarer, Olivier Collard, Marie Karanian, Mehdi Brahmi, Armelle Dufresne, Aurélien Dupré, Françoise Ducimetière, Antoine Giraud, David Pérol, Maud Toulmonde, Isabelle Ray‐Coquard, Antoîne Italiano, Axel Le Cesne, Nicolas Penel, Sylvie Bonvalot - Annals of Oncology 2019 被引用: 332

  14. Improved survival using specialized multidisciplinary board in sarcoma patients

    著者: Jean‐Yves Blay, Pauline Soibinet, Nicolas Penel, Emmanuelle Bompas, Florence Duffaud, Eberhard Stoeckle, Olivier Mir, Julien Adam, Christine Chevreau, Sylvie Bonvalot, María Rios, Pierre Kerbrat, Didier Cupissol, Philippe Anract, F. Gouin, Jean‐Emmanuel Kurtz, Célèste Lebbé, Nicolás Isambert, François Bertucci, M. Toumonde, A. Thyss, Sophie Piperno‐Neumann, Pascale Dubray‐Longeras, Pierre Méeus, Françoise Ducimetière, Antoine Giraud, Jean‐Michel Coindre, Isabelle Ray‐Coquard, Antoîne Italiano, Axel Le Cesne - Annals of Oncology 2017 被引用: 362

  15. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

    著者: Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette, Sophie Piperno‐Neumann, Nicolas Penel, Emmanuelle Bompas, Corinne Delcambre, Elsa Kalbacher, Antoîne Italiano, Olivier Collard, Christine Chevreau, Esma Saâda, Nicolás Isambert, Jessy Delaye, Camille Schiffler, Corinne Bouvier, Vincent Vidal, Sylvie Chabaud, Jean‐Yves Blay - The Lancet Oncology 2018 被引用: 316

  16. Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

    著者: Nicolas Penel, Binh Bui, Jacques‐Olivier Bay, Didier Cupissol, Isabelle Ray‐Coquard, Sophie Piperno‐Neumann, Pierre Kerbrat, Charles Fournier, S. Taïeb, Marta Jiménez, Nicolás Isambert, Frédéric Peyrade, Christine Chevreau, Emmanuelle Bompas, Étienne Brain, Jean‐Yves Blay - Journal of Clinical Oncology 2008 被引用: 693

  17. Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

    著者: Christian Pfister, Gwénaëlle Gravis, Aude Fléchon, Christine Chevreau, Hakim Mahammedi, Brigitte Laguerre, Aline Guillot, Florence Joly, M. Soulié, Yves Allory, Valentin Harter, Stéphane Culine, G. Pignot, J.P. Fendler, Laurent Guy, G. Verhoest, Nicolas Mottet, A. Doerfler, Sophie Abadie Lacourtoisie, A.R. Azzouzi, P. Mongiat, Lionnel Geoffrois, Pascal Eschwège, Frédéric Di Fiore, Guilhem Roubaud, J.L. Hoepffner, Philippe Barthélémy, Hervé Lang, Éric Voog, E. Mandron, Jean Marc Tourani, Camille Serrate, A. Colau, Carolina Saldana, Alexandre de la Taille, Thi Hong Lieu Nguyen, F. Kleinclauss, Yohan LORIOT, Jacques Irani, J.C. Eymard, S. Larré, Olivier Huillard, Marc Zerbib, Frédéric Rolland, J. Rigaud, Nadine Houédé, S. Droupy, Georgina MALOUF, Morgan Rouprêt, S. Vieillot, N. Letang, T. L'Haridon, N. Gaschignard, Werner Hilgers, Jean Louis DAVIN - The Lancet Oncology 2023 被引用: 96

  18. Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    著者: Andrés J.M. Ferreri, Jean‐Yves Blay, Michele Reni, Felice Pasini, Michele Spina, Achille Ambrosetti, Antonello Calderoni, Andrea Rossi, V. Vavassori, Annarita Conconi, Liliana Devizzi, Françoise Berger, Maurilio Ponzoni, Bettina Borisch, Marianne Tinguely, Michele Cerati, Mario Milani, Enrico Orvieto, Juvenal Sánchez, Christine Chevreau, Stefania Dell’Oro, Emanuele Zucca, Franco Cavalli - Journal of Clinical Oncology 2003 被引用: 840

  19. Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?

    著者: Arnaud Méjean, Alain Ravaud, Simon Thézenas, Christine Chevreau, Karim Bensalah, Lionnel Geoffrois, Antoine Thiery-Vuillemin, Luc Cormier, Hervé Lang, Laurent Guy, Gwénaëlle Gravis, Frédéric Rolland, Claude Linassier, É. Lechevallier, Stéphane Oudard, Brigitte Laguerre, Marine Gross‐Goupil, Jean‐Christophe Bernhard, Sandra Colas, Laurence Albigès, Thierry Lebrét, Jean‐Marc Tréluyer, Marc‐Olivier Timsit, Bernard Escudier - European Urology 2021 被引用: 128

  20. Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

    著者: Yann Vano, Réza Elaidi, Mostefa Bennamoun, Christine Chevreau, Delphine Borchiellini, Diane Pannier, Denis Maillet, Marine Gross‐Goupil, Christophe Tournigand, Brigitte Laguerre, Philippe Barthélémy, Elodie Coquan, Gwénaëlle Gravis, Nadine Houédé, Mathilde Cancel, Olivier Huillard, Philippe Beuzeboc, Laure Fournier, Arnaud Méjean, Xavier Cathelineau, N. Doumerc, P. Paparel, Jean‐Christophe Bernhard, Alexandre de la Taille, Karim Bensalah, Thibault Tricard, Thibaut Waeckel, G. Pignot, E. Braychenko, Stefano Caruso, Cheng‐Ming Sun, Virginie Verkarre, Guillaume Lacroix, Marco Moreira, Maxime Meylan, Antoine Bougoüin, Letuan Phan, Christelle Thibault-Carpentier, Jessica Zucman‐Rossi, Wolf H. Fridman, Catherine Sautès‐Fridman, Stéphane Oudard - The Lancet Oncology 2022 被引用: 136

  21. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

    著者: Bernard Escudier, A Płużańska, P. Koralewski, Alain Ravaud, Sergio Bracarda, Cezary Szczylik, Christine Chevreau, M. Filipek, Bohuslav Melichar, Emilio Bajetta, В. А. Горбунова, Jacques‐Olivier Bay, I. Bodrogi, Agnieszka Jagiełło-Gruszfeld, N. Moore - The Lancet 2007 被引用: 2,223

  22. Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

    著者: Olivier Mir, Thomas Brodowicz, Antoîne Italiano, Jennifer Wallet, Jean‐Yves Blay, François Bertucci, Christine Chevreau, Sophie Piperno‐Neumann, Emmanuelle Bompas, Sébastien Salas, Christophe Perrin, Corinne Delcambre, Bernadette Liegl‐Atzwanger, Maud Toulmonde, Sarah Dumont, Isabelle Ray‐Coquard, Stéphanie Clisant, S. Taïeb, Cécile Guillemet, María Rios, Olivier Collard, Laurence Bozec, Didier Cupissol, Esma Saâda-Bouzid, C. Lemaignan, Wolfgang Eisterer, Nicolás Isambert, L. Chaigneau, Axel Le Cesne, Nicolas Penel - The Lancet Oncology 2016 被引用: 279

  23. Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

    著者: Alice Boilève, Maria I. Carlo, Philippe Barthélémy, Stéphane Oudard, Delphine Borchiellini, Martin H. Voss, Saby George, Christine Chevreau, Judith Landman‐Parker, M-D Tabone, D. D. Chism, A. Amin, Mehmet Asım Bilen, Dominick Bossé, Aurore Coulomb L’Herminé, Xiaoping Su, Toni K. Choueiri, Nizar M. Tannir, Gabriel G. Malouf - Journal for ImmunoTherapy of Cancer 2018 被引用: 98

  24. CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment

    著者: Jean‐Emmanuel Kurtz, Xavier Buy, Frédèric Deschamps, Erik Sauleau, Amine Bouhamama, Maud Toulmonde, Charles Honoré, François Bertucci, Mehdi Brahmi, Christine Chevreau, Florence Duffaud, Justine Gantzer, Julien Garnon, Jean‐Yves Blay, Afshin Gangi - European Journal of Cancer 2020 被引用: 94